Understanding Immunotherapy Part 3: CTLA-4

By Amrita Bhatt, MRA Intern | 15 June 2016 In Science, Treatment

Now that you’ve read our background on immunotherapy and learned about PD-1, it’s time to focus on another protein that plays a key role in cancer development, CTLA-4. What is CTLA-4? In addition to displaying PD-1 on the cell surface, T cells also display CTLA-4.

Read More


Research Q&A: Dr. Tim Bullock

21 March 2016 In Science

In the latest blog post, we chatted with the University of Virginia’s Tim Bullock, Ph.D., a tumor immunologist in the Pathology Department and MRA-funded investigator. Read on to learn what he has to say about melanoma research and prevention efforts.

Read More


Understanding Immunotherapy Part 2: PD-1

By Amrita Bhatt, MRA Intern | 17 February 2016 In Science, Treatment

Now that we’ve provided a brief background on immunotherapy, it’s time to dive more deeply into the subject. In the second installment of this blog series, we’ll be examining PD-1, a protein that plays a crucial role in cancer’s ability to hide from our immune systems. What is PD-1? PD-1...

Read More


Researcher Q&A: Dr. John D’Orazio

7 January 2016 In Science

In the latest blog post, we chatted with the University of Kentucky’s John D’Orazio, M.D., Ph.D., a pediatric hematologist oncologist, and a 2015 MRA grant awardee. Read on to learn what he has to say about melanoma research and prevention efforts.

Read More


Researcher Q&A: Dr. Vashisht Yennu Nanda

3 December 2015 In Science

MD Anderson\'s Dr. Yennu Nando explains his research for melanoma.

Read More


Research Q & A: Dr. Michael Atkins

17 November 2015 In Treatment

In the latest blog series, we talked with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Cancer Center at Georgetown University, and a member of the MRA Medical Advisory Panel.

Read More


Login

×